Last year, Elanco Animal Health Inc generated 2.36B USD for its biggest-performing segment, Farm Animal. The International made the largest contribution, accounting for 2.48B USD last year. For the latest quarter, Elanco Animal Health Inc reported the revenue of 718.00M USD for the period ending 2026-06-30, which came from the top-performing segment, Pet Health. International contributed the highest revenue, at 705.00M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Farm Animal

Pet Health

Contract Manufacturing

Food Animal Ruminants Swine

Companion Animal Disease Prevention

Food Animal Future Protein & Health

Companion Animal Therapeutics

Strategic Exits

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Farm Animal

2.36B(50.10%)

2.25B(50.69%)

2.27B(51.41%)

2.22B(50.31%)

2.33B(48.94%)

--(--)

Pet Health

2.30B(48.78%)

2.14B(48.28%)

2.10B(47.63%)

2.14B(48.47%)

2.35B(49.34%)

--(--)

Contract Manufacturing

53.00M(1.12%)

46.00M(1.04%)

42.00M(0.95%)

54.00M(1.22%)

82.00M(1.72%)

--(--)

Food Animal Ruminants Swine

--(--)

1.10B(33.62%)

1.11B(36.15%)

1.17B(38.28%)

Companion Animal Disease Prevention

--(--)

992.70M(30.33%)

787.90M(25.66%)

804.60M(26.24%)

Food Animal Future Protein & Health

--(--)

734.10M(22.43%)

745.10M(24.26%)

711.20M(23.19%)

Companion Animal Therapeutics

--(--)

365.80M(11.18%)

348.00M(11.33%)

283.10M(9.23%)

Strategic Exits

--(--)

80.20M(2.45%)

79.70M(2.60%)

93.90M(3.06%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

International

United States

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

International

2.48B(52.62%)

2.40B(54.13%)

2.43B(55.11%)

2.45B(55.45%)

2.64B(55.42%)

1.80B(54.92%)

1.55B(50.35%)

1.58B(51.64%)

United States

2.23B(47.38%)

2.04B(45.87%)

1.98B(44.89%)

1.97B(44.55%)

2.12B(44.58%)

1.48B(45.08%)

1.52B(49.65%)

1.48B(48.36%)